Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

High Incidence of Herpes Zoster after Cord Blood Hematopoietic Cell Transplant Despite Longer Duration of Antiviral Prophylaxis

Elisabetta Xue, MD, Hu Xie, Wendy Leisenring, ScD, Louise E Kimball, PhD RN, Sonia Goyal, Lisa Chung, Rachel Blazevic, Byron Maltez, Ann Dahlberg, MD, Rachel B. Salit, MD, Colleen Delaney, MD MSc, Steven A. Pergam, MDMPH, Michael Boeckh, MD, Filippo Milano, MD PhD, Joshua Aiden Hill, MD

Blood (2019) 134 (Supplement_1): 4556.

https://doi.org/10.1182/blood-2019-124211

Published: 2019

Journal Articles

Response to the Shingrix Varicella Zoster Virus (VZV) Vaccine in Patients with Chronic Lymphocytic Leukemia (CLL) That Are Treatment Naive or Treated with a Bruton's Tyrosine Kinase Inhibitor (BTK-I)

Christopher Pleyer, MD, Jeffrey Cohen, MD, Susan Soto, Mir Ali, PhD, Inhye E Ahn, MD, Pia Nierman, BSN, MA, RN, Janet Valdez, Jennifer Lotter, PA-C, Jeanine Superata, RN, Xin Tian, Adrian Wiestner, MD PhD, Clare Sun, MD

Blood (2019) 134 (Supplement_1): 3053.

https://doi.org/10.1182/blood-2019-121675

Published: 2019

Journal Articles

An Individualized Risk Mitigation Approach for Safety: Experience from the Mosunetuzumab (CD20/CD3 Bispecific Antibody) Development Program in Relation to Neurotoxicity Risk

Catherine Diefenbach, MD, Sarit Assouline, MD, Francesc Bosch, MD PhD, Chan Y. Cheah, Won Seog Kim, MD PhD, Matthew J Matasar, MD, Carlos Panizo, MD PhD, Dok Hyun Yoon, MD PhD, Brendan Bender, PhD, Genevive Hernandez, PhD, Chi-Chung Li, PhD, Bruce McCall, MD, Carol O'Hear, MD PhD, Michael C Wei, MD PhD, Shen Yin, PhD, Kasra Yousefi, MSc, Antonia Kwan, MD PhD MRCPCH, Loretta J. Nastoupil, MD MSc

Blood (2019) 134 (Supplement_1): 4728.

https://doi.org/10.1182/blood-2019-123757

Published: 2019

Journal Articles

B-Cell Lymphoma Patients Have a 10% Risk of Shingles, 7% in Cutaneous T-Cell Lymphoma

Syed Basir Hussaini, BS, Jacqueline Chu, BA, Nita Williams, BS, Nidhi Sharma, PhD, Don M Benson, Jr., MD PhD, Ashley E Rosko, MD, Yvonne A Efebera, MD, Craig C Hofmeister, MDMPH

Blood (2017) 130 (Supplement 1): 3356.

https://doi.org/10.1182/blood.V130.Suppl_1.3356.3356

Published: 2017

Journal Articles

Effectiveness of Acyclovir Prophylaxis Against Varicella Zoster Virus Infection after Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis

Yuko Shimosato-Wada, Reo Tanoshima, Kanako Hiratoko, Masanobu Takeuchi, Shinichi Tujimoto, Norio Shiba, Shinya Ito, Takeharu Yamanaka, Shuichi Ito

Blood (2017) 130 (Supplement 1): 3231.

https://doi.org/10.1182/blood.V130.Suppl_1.3231.3231

Published: 2017

Journal Articles

High Risk of Infections in Chronic Lymphocytic Leukemia Patients Treated with B-Cell Receptor Inhibitors

Annalynn M Williams, MS, Andrea M Baran, MS, Philip J Meacham, MS, Megan Herr, BS, Hugo E. Valencia, MD, Catherine Newsom, Nealansh Gupta, Michelle Janelsins, PhD, Paul M. Barr, Clive S Zent, MD

Blood (2016) 128 (22): 3203.

https://doi.org/10.1182/blood.V128.22.3203.3203

Published: 2016

Journal Articles

Incidence and Risk Factors for Vzv Infection after Allogeneic Hematopoietic Cell Transplantation in 1,045 Patients: Younger Age Less Than or Equal to 45, Occurrence of Cgvhd By NIH Consensus Criteria, and No T-Cell Depletion

Sita D. Bhella, MD, Elizabeth Shin, Marc Poch Martell, MD, Jieun Uhm, MD, Fotios V. Michelis, MDPhD, Auro Viswabandya, MD DM, Jeffrey H. Lipton, MD PhD, Hans A. Messner, MD/PhD, Dennis Dong Hwan Kim, MD PhD

Blood (2015) 126 (23): 1921.

https://doi.org/10.1182/blood.V126.23.1921.1921

Published: 2015

Journal Articles

Evaluation of Varicella Zoster Prophylaxis after Allogeneic Hematopoietic Cell Transplantation Using Valacyclovir Followed By Vaccination

Kareem Jamani, MD, Andrew Daly, MD FRCPC, Jan Storek, MD PhD

Blood (2015) 126 (23): 1963.

https://doi.org/10.1182/blood.V126.23.1963.1963

Published: 2015

Journal Articles

Use of the Japanese Live Attenuated High-Titer Varicella Vaccine in Pediatric Allogeneic Hematopoietic Stem Cell Transplantation Recipients

Takahiro Aoki, MD, Katsuyoshi Koh, MD, Yutaka Kawano, MD PhD, Chigusa Oyama, MD, Yuhachi Ikeda, MD, Yasuo Kubota, MD, Kiyotaka Isobe, MD, Ryo Oyama, MD, Makiko Mori, MD, Yuki Awakawa, MD, Motohiro Kato, MD PhD, Ryoji Hanada, MD

Blood (2014) 124 (21): 2505.

https://doi.org/10.1182/blood.V124.21.2505.2505

Published: 2014

Journal Articles

Incidence and Risk of Post-Herpetic Neuralgia after Varicella Zoster Virus (VZV) Infection in Hematopoietic Cell Trasnplantation (HCT) Recipients.

Masahiro Onozawa, Satoshi Hashino, Takashi Fukuhara

Blood (2008) 112 (11): 1152.

https://doi.org/10.1182/blood.V112.11.1152.1152

Published: 2008

Journal Articles

Long-Term Ultra-Low-Dose Acyclovir Against Varicella-Zoster Virus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation.

Yuki Asano-Mori, MD, Yoshinobu Kanda, M.D., PhD, Kumi Oshima, M.D., PhD, Shinichi Kako, M.D., Akihito Shinohara, M.D., Hideki Nakasone, M.D., Hiroyuki Sato, M.D., PhD, Takuro Watanabe, M.D., PhD, Noriko Hosoya, M.D., PhD, Koji Izutsu, M.D., PhD, Takashi Asai, M.D., PhD, Akira Hangaishi, M.D., PhD, Toru Motokura, M.D., PhD, Shigeru Chiba, M.D., PhD, Mineo Kurokawa, M.D., PhD

Blood (2007) 110 (11): 1967.

https://doi.org/10.1182/blood.V110.11.1967.1967

Published: 2007

Journal Articles

Acyclovir To Prevent Herpes Zoster in Myeloma Patients Treated with Bortezomib.

Eric Vickrey, Sharon Fellingham, Jayesh Mehta, Seema Singhal

Blood (2007) 110 (11): 4807.

https://doi.org/10.1182/blood.V110.11.4807.4807

Published: 2007

Journal Articles

The Treatment of Delayed Rejection after Boosting of Mononuclear Cells of Her Mother and Chronic Graft Versus Host Disease in Leukemia Recipient Who Underwent Allogeneic Hyplo-Identical Transplantation in Second Remission with Therapeutic Plasma Exchange.

Zhisheng Jiang, MD, Da Li, MD, Shunjie Wu, MD, Kun Liu, MD, Ying Kang, MD, Gi Chen, MD, Xinghao Lan, MD, Suiquan Chen, MD, Wei Yi, MD

Blood (2006) 108 (11): 5237.

https://doi.org/10.1182/blood.V108.11.5237.5237

Published: 2006

Journal Articles

Acute Zoster Pain (AZP) and Post-Herpetic Neuralgia (PHN) in the Course of Lymphoproliferative Disorders (LPD): Durable Pain Relief Provided by Oxycodone in Patients Unresponsive to Standard Therapy.

Pasquale Niscola, MD, Claudio Romani, MD, Alessio Pio Perrotti, MD, Giovanni Del Poeta, MD, Claudio Cartoni, MD, Massimiliano Palombi, MD, Marco Giovannini, MD, Luca Cupelli, MD, Paolo De Fabritiis, MD

Blood (2006) 108 (11): 5500.

https://doi.org/10.1182/blood.V108.11.5500.5500

Published: 2006

Journal Articles

Delayed Varicella Zoster Virus (VZV) Infection Following Hematopoietic Cell Transplantation (HCT).

Liton Francisco, BS, Mary Harton, M.P.H., Can-Lan Sun, Ph.D., Andrea R. Carter, B.A., John Zaia, M.D., Stephen J. Forman, M.D., Sanjeet Dadwall, M.D., Smita Bhatia, M.D., M.P.H.

Blood (2006) 108 (11): 3366.

https://doi.org/10.1182/blood.V108.11.3366.3366

Published: 2006

Journal Articles

Factors Influencing Varicella-Zoster Virus (VZV) Infection after Allogeneic Peripheral Blood Stem Cell Transplantation: Low-Dose Acyclovir Prophylaxis and Pre-Transplant Diagnosis of Lymphoproliferative Disorders.

Dong Hwan Kim, MD, PhD, Hans Messner, MD, PhD, Vikas Gupta, MD, MRCP, John Kuruvilla, MD, Janice Wright, MS, ACNP(C), Jeffrey Lipton, MD, PhD

Blood (2006) 108 (11): 3373.

https://doi.org/10.1182/blood.V108.11.3373.3373

Published: 2006

Journal Articles

Herpes Zoster (HZ) Infection in the Post-Hematopoietic Stem Cell Transplant Pediatric Population May Be Preceded by Transaminitis.

Jason N. Berman, M.D., Winter Berry, Molin Wang, PhD., Donna S. Neuberg, ScD., Eva C. Guinan, M.D.

Blood (2004) 104 (11): 3167.

https://doi.org/10.1182/blood.V104.11.3167.3167

Published: 2004

NARROW

High Incidence of Herpes Zoster after Cord Blood Hematopoietic Cell Transplant Despite Longer Duration of Antiviral Prophylaxis

Response to the Shingrix Varicella Zoster Virus (VZV) Vaccine in Patients with Chronic Lymphocytic Leukemia (CLL) That Are Treatment Naive or Treated with a Bruton's Tyrosine Kinase Inhibitor (BTK-I)

An Individualized Risk Mitigation Approach for Safety: Experience from the Mosunetuzumab (CD20/CD3 Bispecific Antibody) Development Program in Relation to Neurotoxicity Risk

B-Cell Lymphoma Patients Have a 10% Risk of Shingles, 7% in Cutaneous T-Cell Lymphoma

Effectiveness of Acyclovir Prophylaxis Against Varicella Zoster Virus Infection after Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis

High Risk of Infections in Chronic Lymphocytic Leukemia Patients Treated with B-Cell Receptor Inhibitors

Incidence and Risk Factors for Vzv Infection after Allogeneic Hematopoietic Cell Transplantation in 1,045 Patients: Younger Age Less Than or Equal to 45, Occurrence of Cgvhd By NIH Consensus Criteria, and No T-Cell Depletion

Evaluation of Varicella Zoster Prophylaxis after Allogeneic Hematopoietic Cell Transplantation Using Valacyclovir Followed By Vaccination

Use of the Japanese Live Attenuated High-Titer Varicella Vaccine in Pediatric Allogeneic Hematopoietic Stem Cell Transplantation Recipients

Incidence and Risk of Post-Herpetic Neuralgia after Varicella Zoster Virus (VZV) Infection in Hematopoietic Cell Trasnplantation (HCT) Recipients.

Long-Term Ultra-Low-Dose Acyclovir Against Varicella-Zoster Virus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation.

Acyclovir To Prevent Herpes Zoster in Myeloma Patients Treated with Bortezomib.

The Treatment of Delayed Rejection after Boosting of Mononuclear Cells of Her Mother and Chronic Graft Versus Host Disease in Leukemia Recipient Who Underwent Allogeneic Hyplo-Identical Transplantation in Second Remission with Therapeutic Plasma Exchange.

Acute Zoster Pain (AZP) and Post-Herpetic Neuralgia (PHN) in the Course of Lymphoproliferative Disorders (LPD): Durable Pain Relief Provided by Oxycodone in Patients Unresponsive to Standard Therapy.

Delayed Varicella Zoster Virus (VZV) Infection Following Hematopoietic Cell Transplantation (HCT).

Factors Influencing Varicella-Zoster Virus (VZV) Infection after Allogeneic Peripheral Blood Stem Cell Transplantation: Low-Dose Acyclovir Prophylaxis and Pre-Transplant Diagnosis of Lymphoproliferative Disorders.

Herpes Zoster (HZ) Infection in the Post-Hematopoietic Stem Cell Transplant Pediatric Population May Be Preceded by Transaminitis.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only